Burney Co/ »

Apellis Pharmaceuticals shares owned by Burney Co/

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Burney Co/ from 13F filings

Historical chart of Burney Co/ investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Burney Co/ consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Burney Co/

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 62k 40.23

More positions owned by Burney Co/

Ea Series Trust Burney Us Eqty
Ea Series Trust Burney Us Fctr (BRNY)
Apple (AAPL)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Lam Research Corp Com New (LRCX)
Meta Platforms Cl A (META)
Parker-Hannifin Corporation (PH)
Dimensional Etf Trust Intl Core Equity (DFIC)
McKesson Corporation (MCK)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Arista Networks Com Shs (ANET)
Expedia Group Com New (EXPE)

View all positions for Burney Co/

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals